Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development. (July 2015)

• Record Type: Journal Article
• Authors: Meechan, Daniel W.; Maynard, Thomas M.; Tucker, Eric S.; Fernandez, Alejandra; Karpinski, Beverly A.; Rothblat, Lawrence A.; LaMantia, Anthony-S.
• Is Part Of: Progress in neurobiology. Volume 130(2015:Jul.)
• Page Start: 1
• Page End: 28
• Publication Date: 2015-07
• Subjects: ASD autism spectrum disorder -- ADHD attention deficit disorder -- CGE caudal ganglionic eminence -- CN cranial nerve -- CNV copy number variant -- DTI diffusion tensor imaging -- fMRI functional magnetic resonance imaging -- hChr human chromosome -- LCR low copy repeat -- LGE lateral ganglionic eminence -- MB megabase -- MGE medial ganglionic eminence -- mFAC medial frontal anterior cortex -- MRI magnetic resonance imaging -- MRS magnetic resonance spectroscopy -- NAHR non-allelic homologous recombination -- OFC orbital frontal cortex -- PH periventricular heterotopias -- PMG polymicrogyria -- SCZ schizophrenia -- SD segmental duplication -- SVZ subventricular zone -- VZ ventricular zone; Schizophrenia -- Autism -- ADHD -- Cortex -- Animal models; Neurobiology -- Periodicals; Neurology -- Periodicals; Neurology -- Periodicals; Neurobiologie -- Périodiques; 612.8
• DOI: 10.1016/j.pneurobio.2015.03.004
• Languages: English
• ISSNs: 0301-0082

Abstract

Highlights: 22q11DS is a common chromosomal copy number variant genetic disorder. Developmental disorders autism, ADHD and schizophrenia are prevalent in 22q11DS. 22q11DS models have revealed cellular defects during embryonic development. These defects perturb cortical circuit formation and function. Model studies provide a foundation for determining causes of developmental disorders. Abstract: Understanding the developmental etiology of autistic spectrum disorders, attention deficit/hyperactivity disorder and schizophrenia remains a major challenge for establishing new diagnostic and therapeutic approaches to these common, difficult-to-treat diseases that compromise neural circuits in the cerebral cortex. One aspect of this challenge is the breadth and overlap of ASD, ADHD, and SCZ deficits; another is the complexity of mutations associated with each, and a third is the difficulty of analyzing disrupted development in at-risk or affected human fetuses. The identification of distinct genetic syndromes that include behavioral deficits similar to those in ASD, ADHC and SCZ provides a critical starting point for meeting this challenge. We summarize clinical and behavioral impairments in children and adults with one such genetic syndrome, the 22q11.2 Deletion Syndrome, routinely called 22q11DS, caused by micro-deletions of between 1.5 and 3.0 MB on human chromosome 22. Among many syndromic features, including cardiovascular and craniofacial anomalies, 22q11DS patients have a high incidence of brain structural, functional, and behavioral deficits that reflect cerebral cortical dysfunction and fall within the spectrum that defines ASD, ADHD, and SCZ. We show that developmental pathogenesis underlying this apparent genetic "model" syndrome in patients can be defined and analyzed mechanistically using genomically accurate mouse models of the deletion that causes 22q11DS. We conclude that "modeling a model", in this case 22q11DS as a model for idiopathic ASD, ADHD and SCZ, as well as other behavioral disorders like anxiety frequently seen in 22q11DS patients, in genetically engineered mice provides a foundation for understanding the causes and improving diagnosis and therapy for these disorders of cortical circuit development.